Equity Capital Markets

Company · CIK 1778016

NovaBridge Biosciences

CIK1778016 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inE9
Business addressMD
ListedNBP (Nasdaq)
First annual or quarterly report2020-04-29

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-286954
ShelfEffective
 2025-05-022025-08-044
333-251050
Registered companyEffective
 2020-12-012021-03-235
333-234363
IPOFinal prospectus
 2019-10-292020-01-216

Filings

19
FiledFilingRegistrationAccession
2025-08-04424B5Shelf takedown 333-2869540001193125-25-172159
2025-07-11424B5Shelf takedown 333-2869540001193125-25-158201
2025-05-15EFFECTDeclared effective 333-2869549999999995-25-001626
2025-05-02F-3Shelf registered 333-2869540001193125-25-111693
2021-03-23EFFECTDeclared effective 333-2510509999999995-21-001076
2021-02-09424B5Shelf takedown 333-2527930001193125-21-034299
2021-02-08424B5Shelf takedown 333-2510500001193125-21-030991
2021-02-05424B5Shelf takedown 333-2527930001193125-21-030923
2021-02-05424B5Shelf takedown 333-2510500001193125-21-029918
2020-12-14EFFECTDeclared effective 333-2510509999999995-20-003515
2020-12-01F-1Registration filed 333-2510500001193125-20-307060
2020-01-21424B4Final prospectus 333-2343630001193125-20-010505
2020-01-16EFFECTDeclared effective 333-2355579999999995-20-000105
2020-01-16EFFECTDeclared effective 333-2343639999999995-20-000102
2020-01-14F-1/AAmendment 333-2343630001193125-20-006783
2020-01-03F-1/AAmendment 333-2343630001193125-20-000969
2019-11-04F-1/AAmendment 333-2343630001193125-19-283041
2019-10-29F-1Registration filed 333-2343630001193125-19-277698
2019-07-29DRSDraft made public 377-027580000950123-19-006688

All filings of this company · CSV